Jerzy Gumulka - Apr 19, 2023 Form 4 Insider Report for CNS Pharmaceuticals, Inc. (CNSP)

Role
Director
Signature
/s/ Christopher Downs, Attorney-in-Fact
Stock symbol
CNSP
Transactions as of
Apr 19, 2023
Transactions value $
$4,250
Form type
4
Date filed
4/21/2023, 07:58 AM
Previous filing
Apr 17, 2023
Next filing
Oct 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNSP Common Stock Purchase $4.25K +2.5K +34.85% $1.70 9.67K Apr 19, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.